kaia health software GmbH

DED2601V.HRB224467|Herzog-Wilhelm-Straße 26, 80331 MünchenGermany|2016

Profit-€7.9M

Balance€56.9M

About

kaia health software GmbH, based in Munich, develops digital health applications (DiGA) for the treatment of chronic conditions such as back pain and COPD. The company distributes its products primarily through the German DiGA channel, with costs for the back pain program covered by statutory health insurance funds. Additionally, the company is expanding into the international market for musculoskeletal disorders through a US subsidiary. To finance development and market launch, the company utilizes both equity and milestone payments from pharmaceutical partners.

Business purpose (commercial register)

Entwicklung und Vertrieb von Software für Menschen, die an chronischen Krankheiten leiden.

ClassificationWZ 2025

K.62.10.9 - Programmierungstätigkeiten a. n. g.

Network

CompanyPersonShareholdingOfficer or Prokura

Products

Digitalegesundheit Therapie

Opportunities & Risks

Wachstum Digitalisierung Künstliche Intelligenz Technologie Partnerschaften Skaleneffekte Produktgruppen

Liquiditätsrisiken Datenschutz Regulatorische Anforderungen Wettbewerbsdruck Finanzierungsrisiken Personalmangel Preisdruck Regulatorische Vorgaben

This summary was generated with the help of AI. See our Data Quality Notice. Report error?

Source: German Commercial Register (Handelsregister) München Local Court, HRB 224467 (as of 26 September 2026)

Company Structure

Shareholders

Name	Type	City
Graham Lewis	Geschäftsführer(in)	München

Source: German Commercial Register (Handelsregister) München Local Court, HRB 224467 (as of 26 September 2026)

Financials

Key financial figures over time — kaia health software GmbH
Year	Revenue	Profit	Balance	Employees
2024	Rohergebnis€1.3M²	-€7,855,791	€56,888,462	—
2023	Rohergebnis-€495.9K²	-€11,497,924	€65,234,129	—
2022	Rohergebnis€1.3M²	-€12,164,185	€68,692,744	—
2021	Rohergebnis€5.3M²	-€3,567,892	€75,805,842	—
2020	≤ €12M¹	-€4,194,760	€27,415,545	—
2019	≤ €12M¹	-€4,578,156	€9,785,706	—
2018	≤ €12M¹	-€1,898,239	€9,237,200	—
2017	—	-€1,274,599	€1,715,337	—

¹ Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.

² Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.

Source: German Company Register (Unternehmensregister)